微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 24.52% | -19.05% | -7.1% | 40/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 26.4% | -7.02% | 4.22% | 39/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 25.33% | 3.02% | -16.71% | 38/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 30.41% | 11.42% | 0.37% | 38/51 | 38.12% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 30.29% | 23.21% | 6.7% | 41/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 28.39% | 15.03% | 15.49% | 42/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 24.58% | 10.75% | -9.92% | 43/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 27.29% | 4.63% | 11% | 42/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 24.59% | 2% | -0.38% | 42/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 24.68% | -10.56% | 11.18% | 43/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 22.2% | 2% | -14.9% | 39/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 26.08% | -10.44% | -5.47% | 45/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-06-30 | 27.59% | -5.41% | -5.26% | 41/51 | 42.6% | 南华生物 | 84.53% | 行业排名> |
| 2020-12-31 | 29.12% | -11.41% | -0.16% | 42/51 | 38.51% | 南华生物 | 83.19% | 行业排名> |
| 2020-06-30 | 29.17% | -11.39% | -11.28% | 30/51 | 39.28% | 南华生物 | 83.9% | 行业排名> |
| 2019-12-31 | 32.88% | 1.08% | 1.08% | 41/51 | 42.94% | 成都先导 | 79.36% | 行业排名> |
| 2018-12-31 | 32.53% | -5.13% | -1.19% | 40/51 | 42.09% | 成都先导 | 75.92% | 行业排名> |
| 2018-06-30 | 32.92% | -6.41% | -3.99% | 27/51 | 43.98% | 南华生物 | 78.74% | 行业排名> |
| 2017-12-31 | 34.28% | 2% | -2.52% | 29/51 | 40.94% | 成都先导 | 80.82% | 行业排名> |
| 2017-06-30 | 35.17% | 2% | 2% | 21/51 | 43.6% | 成都先导 | 81.55% | 行业排名> |